Stroke remains a leading cause of morbidity and mortality worldwide. Early recognition and prompt intervention can significantly improve patient outcomes. This article aims to provide healthcare professionals with a comprehensive guide to early stroke recognition and management.
Stroke symptoms typically occur suddenly and may include: numbness or weakness in the face, arm, or leg, especially on one side of the body; confusion, trouble speaking or understanding speech; difficulty seeing in one or both eyes; trouble walking, dizziness, or loss of balance or coordination; severe headache with no known cause. The acronym FAST (Face drooping, Arm weakness, Speech difficulty, Time to call 911) can be useful in identifying stroke symptoms quickly.
Initial management of suspected stroke includes stabilizing the patient, ensuring adequate oxygenation, and obtaining a non-contrast CT scan of the head to differentiate between ischemic and hemorrhagic stroke. In cases of ischemic stroke, intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) may be administered if the patient presents within 4.5 hours of symptom onset and there are no contraindications.
Secondary prevention strategies aim to reduce the risk of recurrent stroke. These include lifestyle modifications (smoking cessation, healthy diet, regular exercise), blood pressure control, lipid management, and antithrombotic therapy. In patients with non-cardioembolic ischemic stroke or transient ischemic attack (TIA), antiplatelet agents such as aspirin or clopidogrel are recommended.
Early recognition and management of stroke can significantly improve patient outcomes. Healthcare professionals play a critical role in this process. Continued education on stroke recognition and management is essential to ensure optimal patient care.
1.
Race, Geography Linked to Gaps in Prostate Cancer Care
2.
Sports for girls are frequently abandoned due to uniform issues.
3.
According to the Lancet, having cancer and VTE at the same time increases mortality risk.
4.
Temsirolimus Plus Chemotherapy Fails in Rare Childhood Cancer
5.
Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma
1.
Hematopoietic Clonal Competition in Blood Disorders
2.
Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond
3.
Developmental Iron Biology Beyond Infancy: Mechanisms, Clinical Implications, and Emerging Directions
4.
Next-Generation Bone Marrow Harvest Technologies
5.
Strategic Applications in Hematology in Clinical Decision-Making
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding the Common Causes of Anemia
2.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation